- Current report filing (8-K)
15 5월 2012 - 5:50AM
Edgar (US Regulatory)
SECURITIES AND EXCHANGE COMMISSION
Washington, DC20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
May 8, 2012
Commission File Number:
000-53750
PROTEONOMIX, INC.
(Name of Registrant in Its Charter)
|
|
Delaware
(State or Other Jurisdiction of
Incorporation or Organization)
|
45-5185575
(I.R.S. Employer Identification No.)
|
145 Highview Terrace, Hawthorne, NJ 07506
(Address of Principal Executive Offices)
(Zip Code)
(973) 544-6116
(Issuer’s Telephone Number, Including
Area Code)
N/A
(Former name or former
address, if changed since last report)
Check the appropriate box below if the Form 8-K filing
is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General
Instruction A.2. below):
¨
Written communications
pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨
Soliciting material pursuant
to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨
Pre-commencement communications
pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨
Pre-commencement communications
pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
ITEM4.01CHANGES IN REGISTRANT’S CERTIFYING ACCOUNTNAT
Previous independent registered public
accounting firm
(a) On May 8, 2012, Proteonomix, Inc. (the
“Registrant” or the “Company”) was notified by KJPDH & COMPANY (“KJPDH & COMPANY”)
that they have resigned as the Registrant’s independent registered public accounting firm. The resignation of KJPDH &
COMPANY as the Company’s independent registered public accounting firm was accepted by the Company’s Board of Directors
on May 9, 2012. KJPDH & COMPANY issued no reports on the Company’s financial statements and thus no reports contained
an adverse opinion or disclaimer of opinion, and such reports were not qualified or modified as to uncertainty, audit scope or
accounting principle.
KJPDH & COMPANY had been retained by
the Company on April 25, 2012. The previous independent registered accounting firm, KBL, LLP, issued financial statements for the
years ended December 31, 2011 and 2010 containing explanatory paragraphs which noted that there was substantial doubt as to the
Company’s ability to continue as a going concern as the Company has negative working capital, and substantial accumulated
deficits. These factors raise substantial doubt about the ability of the Company to continue as a going concern.
During the period from April 25, 2012 through
May 8, 2012, the Company had not had any disagreements with KJPDH & COMPANY on any matter of accounting principles or practices,
financial statement disclosure or auditing scope or procedure, which disagreements, if not resolved to KJPDH & COMPANY’s
satisfaction, would have caused them to make reference thereto in their reports on the Company’s financial statements for
such periods.
During the years ended December 31, 2011
and 2010 and through May 8, 2012, there were no reportable events, as defined in Item 304(a)(1)(v) of Regulation S-K.
The Company provided KJPDH & COMPANY
with a copy of this disclosure set forth under this Item 4.01 and was requested to furnish a letter addressed to the Securities
& Exchange Commission stating whether or not it agrees with the above statements.
A copy of this letter from KJPDH &
COMPANY is attached hereto as Exhibit 16.1.
New independent registered public
accounting firm
On May 11, 2012 (the “Engagement
Date”), the Company engaged Demetrius & Company, L.L.C. (“Demetrius”) as its independent registered public
accounting firm. The decision to engage JPDH as the Company’s independent registered public accounting firm was approved
by the Company’s Board of Directors.
During the years
ended December 31, 2011 and 2010, and through May 11, 2012, (the date Demetrius was appointed), the Company did not consult Demetrius
with respect to the application of accounting principles
to any
specified transaction, either
completed or proposed, or the type of audit opinion that might be rendered on the Company’s Financial Statements, or any
other matters or reportable events as defined in Item 304(a)(2)(i) and (ii) of Regulation S-K.
ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS
(a)
Financial statements of business acquired.
Not applicable
(b)
Pro forma financial information.
Not applicable
(c)
Shell company transactions.
Not applicable
(d)
Exhibits
|
ExhibitNo.
|
Description of Filing
|
|
16.1
|
Letter from KJPDH & COMPANY, LLP
|
SIGNATURE
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
PROTEONOMIX, INC.
Dated: May 14, 2012
By:
/s/Michael Cohen
Name: Michael Cohen
President
Proteonomix (CE) (USOTC:PROT)
과거 데이터 주식 차트
부터 2월(2) 2025 으로 3월(3) 2025
Proteonomix (CE) (USOTC:PROT)
과거 데이터 주식 차트
부터 3월(3) 2024 으로 3월(3) 2025